Halle Berry Advocates for $275M Menopause Research Funding with Bipartisan Senators


Renowned actress Halle Berry is making waves from Hollywood to the capital, joining forces with a bipartisan group of senators to champion a significant and somewhat overlooked cause: menopause. The proposed legislation earmarks $275 million for research and education centered around this crucial chapter of women’s lives, which ushers in a significant hormonal shift during middle age.

The bill seeks to ramp up federally funded research, with a focus on high-quality clinical trials into hormone therapy – a key form of treatment designed to dissipate hot flashes and other distressing symptoms often experienced during menopause.

Follow us on Google News! ✔️

Leaving her mark at the U.S. Capitol, Berry, aged 57, addressed the crowd gathered, lifting the veil off the stigma surrounding menopause. Expressing her dismay over the prevailing reluctance of even medical professionals to properly name the condition, she incited laughter by making her stand:

“I’m in menopause, OK?” she uttered from the Capitol steps. “The shame has to be taken out of menopause. We have to honestly discuss this natural stage of life that we inevitably go through. If our doctors themselves stumble while trying to say the word, how can they guide us effectively through the journey?”

The A-list actress has not shied away from sharing her own firsthand experiences of perimenopause, the prelude to menopause, characterized by the gradual descent of a woman’s estrogen levels. She spoke openly about the debilitating symptoms she was faced with, and shockingly, the initial misdiagnosis that she had contracted herpes, despite both her and her partner testing negative for the sexually transmitted disease.

The proposed bill, presented by Democratic Sen. Patty Murray of Washington and Republican Sen. Lisa Murkowski of Alaska, allocates $125 million specifically for clinical trials, public health initiatives, and medical research on menopause. The remainders are purposed for enhancing diagnosis, further educating doctors on administration of menopause treatment, and elevating public awareness regarding the matter.

Sen. Murray appositely commented, “Menopause is not a disgraceful term, it’s not a cause of shame, and it’s unquestionably not a matter that Congress or the federal government can afford to sideline.”

Attracting the endorsement of 17 senators – a diverse mix of three Republicans, 13 Democrats, one independent, with the commonality of them all being women – the senators expressed hopes that the bill’s backing may catalyze more transparent dialogue about this health juncture experienced by all women.

In alignment with these sentiments, other celebrities have been seen discussing menopause more openly on talk shows and interviews, while some have begun promoting products related to the condition. Just last year, President Joe Biden introduced an initiative aiming to refine research on women’s health within federal government, encompassing menopause.

However, the bill’s success is far from certain. Navigating through Congress’ political discord, and facing a shrinking legislative calendar before the imminent November election, are considerable obstacles the advocates must overcome. Achieving consensus from the male majority on Capitol Hill will be a defining step in converting these plans for menopause research into tangible reality.

In a rallying cry for support, Sen. Murkowsi made a pointed observation: “Had men been susceptible to menopause, we would have seen adequate funding directed towards menopause research decades ago.”